Changing Pattern of Histone H3 Methylation following treatment of erythroid progenitors derived from cord blood CD133+ cells with sodium butyrate and thalidomide

Journal Title: Iranian Journal of Blood and Cancer - Year 2012, Vol 4, Issue 2

Abstract

Background: Human β-like globin genes regulaon during development from embyonic to adult stage results in generaon of different types of hemoglobin with different funcons. As β-thalassemia and sickle cell disease are disorders of β-globin chain, epigenec drugs such as thalidomide and sodium butyrate which can induce γ-globin gene are considered as a novel therapeuc approach. Drugs effecve in decreasing DNA methylaon and alteraon of histone methylaon pa$ern can result in γ-globin gene upregulaon. Materials and Methods: This study was performed on erythroid progenitors derived from cord blood CD133+ cells. Erythroid progenitors were treated with thalidomide and sodium butyrate as single and combinaon therapies in 10 μM concentraons. Chroman Immuno Percipitaon (ChIP) assay was used to evaluate the change in H3K27 methylaon pa$ern. Also, Real-me PCR assay was used to compare the number of DNA fragments resulng from immunoprecipitaon in different drug treatment groups. Results: Real-me PCR assay indicated considerable effect of thalidomide single therapy in decreasing H3K27 methylaon compared with sodium butyrate and combinaon therapy. Conclusion: According to the results of this study, it seems that the synergisc effect of thalidomide and sodium butyrate combinaon therapy on γ-globin gene inducon arises from other epigenec mechanisms.

Authors and Affiliations

Ali Dehghani Fard, Saeid Kaviani, Mehrdad Noruzinia, Masoud Soleimani, Abbas Hajifathali, Ali Akbar Pourfathollah, Yousef Mortazavi, Zahra Zonoubi, Mohammad Ahmadvand, Najmaldin Saki, Majid Farshdusti Hagh

Keywords

Related Articles

Microparticle Formation and Platelet Shrinkage in Type-I Glanzmman Thrombasthenia Platelets

Background: Activated normal platelets undergo many biochemical and morphological changes, some of which are apoptotic. Platelet derived microparticles and shrinked platelets as hallmark of platelet activation and apopto...

Quantitative Immunophemotyping of Platelet Surface Glycoproteins among Iranian Patients with Bernard-Soulier Syndrome

Background: Bernard-Soulier syndrome is a rare inherited bleeding disease caused by quantitative or qualitative defect of GPIb/IX/V, a platelet complex that binds the Von Willebrand factor. The expression of GPIb-IX-V co...

Influences of Genetic Abnormality on the Risk of Acute Lymphoblastic Leukemia

ecent studies have provided evidence that common genetic variations could account for a proportion of leukemia in adult or children. To evaluate the contribution of candidate gene association studies to the understanding...

Myelofibrosis due to Secondary Hyperparathyroidism in a Case of Celiac Disease

Myelofibrosis is reported in patents with primary hyperparathyroidism. It is also was reported in patents with sec- ondary hyperparathyroidism due to end-stage renal disease or Vitamin D dependent rickets .We present a c...

Download PDF file
  • EP ID EP369006
  • DOI -
  • Views 73
  • Downloads 0

How To Cite

Ali Dehghani Fard, Saeid Kaviani, Mehrdad Noruzinia, Masoud Soleimani, Abbas Hajifathali, Ali Akbar Pourfathollah, Yousef Mortazavi, Zahra Zonoubi, Mohammad Ahmadvand, Najmaldin Saki, Majid Farshdusti Hagh (2012). Changing Pattern of Histone H3 Methylation following treatment of erythroid progenitors derived from cord blood CD133+ cells with sodium butyrate and thalidomide. Iranian Journal of Blood and Cancer, 4(2), 53-59. https://europub.co.uk/articles/-A-369006